Mazumdar-Shaw’s Mission to Expand Access to Life-Saving Drugs

✅

Full Article Content Loaded

Complete article with 550 characters of detailed content

Full Article•Reading time: ~2 min•87 words

ℹ️

Chrome Audio Reader: This audio reader has been optimized for Chrome's speech synthesis. If you experience issues, try using Edge or Firefox as they have more reliable speech synthesis.

Chrome Known Issues: Chrome sometimes has voice loading delays. The system will automatically retry with simplified settings if needed. For best results, try Edge or Firefox browsers.

🔇

Audio Reader

Not supported in this browser

Known as India’s ‘Queen of Biotech’, Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world’s biggest producers of insulin, and a leading force in biosimilars.
As she looks at handing over her life’s work to successors, Mazumdar-Shaw talks to Bloomberg’s Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future. (Source: Bloomberg)

Article Details

📰Source: Bloomberg

⚡Content fetched on-demand for optimal performance

✨Enhanced with BBC-inspired formatting

Reading Statistics

550

Characters

Words

Mazumdar-Shaw’s Mission to Expand Access to Life-Saving Drugs

Full Article Content Loaded

Audio Reader

Article Details

Reading Statistics

Share this story

Comments

Leave a Comment

Related Stories

Stay Updated

Trending Now